Table 6.

Studies comparing the overall and cause-specific mortality in no NASH compared to NASH

Study	Year	Population (n)	Follow up (Years)	Comparison Groups	Histology Classification	All-Cause Mortality	Liver- Related Mortality	Cardiovascular Mortality	Cancer related Mortality
Matteoni [15]	1999	132	18	NASH versus steatosis± inflammation	Matteoni	39.7% versus 32.2%●	10.9% versus 1.69%*	NR	NR
Ekstedt [14]	2006	129	13.7	NASH versus steatosis± non-specific inflammation	Brunt	26.7% versus 12%●	2.8% versus none●	15.5% versus 8.6%●	5.6% versus 1.7%●
Rafiq [16]	2009	173	18.5	NASH versus steatosis± non -specific inflammation	Matteoni	No differences between both groups (P=0.30)	17.5% versus 2.5% †	NR	NR
Soderberg [46]	2010	118	45	NASH versus simple steatosis	Kleiner	47 % versus 34.3 %●	5.8% versus 8.9%●	13.7% versus 10.4%●	15.6% versus 7.4%●
Younossi[17]	2011	209	12	NASH versus No NASH	Younossi	30.5% versus 30.8%*	13% versus 1.3% †	NR	NR

NR-Not Reported,

^†- P<0.05,

^●-Significance not reported,

^*-Not significant